METOTREKSAT
Yıl: 2016 Cilt: 50 Sayı: 1(Özel) Sayfa Aralığı: 20 - 23 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022
METOTREKSAT
Öz: -
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Pathirana D, Ormerod AD, Saiag P, et al: European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 2010;24:117-8
- . 2. Kalb RE, Strober B, Weinstein G, Lebwohl M: Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference. J Am Acad Dermatol 2009;60:824-37.
- 3. Yamauchi PS, Rizk D, Kormeili T, Patnaik R, Lowe NJ: Current systemic therapies for psoriasis: where are we now? J Am Acad Dermatol 2003;49(Suppl 2):66-77.
- 4. Strober BE, Menon K: Folate supplementation during methotrexate therapy for patients with psoriasis. J Am Acad Dermatol 2005;53:652-9.
- 5. Meephansan J, Ruchusatsawat K, Sindhupak W, Thorner PS, Wongpiyabovorn J: Effect of methotrexate on serum levels of IL-22 in patients with psoriasis. Eur J Dermatol 2011;21:501-4.
- 6. Bath RK, Brar NK, Forouhar FA, Wu GY: A review of methotrexate-associated hepatotoxicity J Dig Dis 2014;15:517-24.
- 7. Weinstein GD, Frost P: Methotrexate for psoriasis. A new therapeutic schedule. Arch Dermatol 1971;103:33-8.
- 8. Nyfors A, Brodthagen H: Methotrexate for psoriasis in weekly oral doses without any adjunctive therapy. Dermatologica 1970;140:345-55.
- 9. Heydendael VM, Spuls PI, Opmeer BC, et al. Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. N Engl J Med 2003;349:658-65.
- 10. Flytström I, Stenberg B, Svensson A, Bergbrant IM: Methotrexate vs. ciclosporin in psoriasis: effectiveness, quality of life and safety. A randomized controlled trial. Br J Dermatol 2008;158:116-21.
- 11. Asawanonda P, Nateetongrungsak Y: Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: a randomized, placebo-controlled study. J Am Acad Dermatol 2006;54:1013-8.
- 12. Morison WL, Momtaz K, Parrish JA, Fitzpatrick TB: Combined methotrexatePUVA therapy in the treatment of psoriasis. J Am Acad Dermatol 1982;6:46- 51.
- 13. Zachariae C, Mork NJ, Reunala T, et al: The combination of etanercept and methotrexate increases the effectiveness of treatment in active psoriasis despite inadequate effect of methotrexate therapy. Acta Derm Venereol 2008;88:495-501.
- 14. Erickson AR, Reddy V, Vogelgesang SA, West SG: Usefulness of the American College of Rheumatology recommendations for liver biopsy in methotrexatetreated rheumatoid arthritis patients. Arthritis Rheum 1995;38:1115-9.
- 15. Thomas JA, Aithal GP: Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary? Am J Clin Dermatol 2005;6:357-63.
- 16. MacDonald A, Burden AD: Noninvasive monitoring for methotrexate hepatotoxicity. Br J Dermatol 2005;152:405-8.
- 17. Chalmers RJ, Kirby B, Smith A, et al: Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis. Br J Dermatol 2005;152:444-50.
- 18. Bray AP, Barnova I, Przemioslo R, Kennedy CT, et al: Liver fibrosis screening for patients with psoriasis taking methotrexate: a cross-sectional study comparing transient elastography and liver biopsy. Br J Dermatol 2012;166:1125-7.
- 19. Friedrich-Rust M, Ong MF, Martens S, et al: Performance of transient elastography for the staging of liver fibrosis: a metaanalysis. Gastroenterology 2008;134:960-74.
- 20. Gan EY, Chong WS, Tey HL: Therapeutic Strategies in psoriasis patients with psoriatic arthritis: focus on new agents. Bio Drugs 2013;27:359-73.
- 21. Nast A, Boehncke WH, Mrowietz U, et al: S3 - Guidelines on the treatment of psoriasis vulgaris (English version) Update. J Dtsch Dermatol Ges 2012;10(Suppl 2):1-95.
- 22. Aydin F, Canturk T, Senturk N, Turanli AY: Methotrexate and ciclosporin combination for the treatment of severe psoriasis. Clin Exp Dermatol 2006;31:520-4.
- 23. Clark CM, Kirby B, Morris AD, et al: Combination treatment with methotrexate and ciclosporin for severe recalcitrant psoriasis. Br J Dermatol 1999;141:279-82.
- 24. Lowenthal KE, Horn PJ, Kalb RE: Concurrent use of methotrexate and acitretin revisited. J Dermatolog Treat 2008;19:22-6.
- 25. Maini RN, Breedveld FC, Kalden JR, et al: Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 1998;41:1552-63.
- 26. Kaur I, Dogra S, De D, Kanwar AJ: Systemic methotrexate treatment in childhood psoriasis: further experience in 24 children from India. Pediatr Dermatol 2008;25:184-8.
| APA | senturk n (2016). METOTREKSAT. , 20 - 23. |
| Chicago | senturk nilgun METOTREKSAT. (2016): 20 - 23. |
| MLA | senturk nilgun METOTREKSAT. , 2016, ss.20 - 23. |
| AMA | senturk n METOTREKSAT. . 2016; 20 - 23. |
| Vancouver | senturk n METOTREKSAT. . 2016; 20 - 23. |
| IEEE | senturk n "METOTREKSAT." , ss.20 - 23, 2016. |
| ISNAD | senturk, nilgun. "METOTREKSAT". (2016), 20-23. |
| APA | senturk n (2016). METOTREKSAT. Türkderm-Deri Hastalıkları ve Frengi Arşivi, 50(1(Özel)), 20 - 23. |
| Chicago | senturk nilgun METOTREKSAT. Türkderm-Deri Hastalıkları ve Frengi Arşivi 50, no.1(Özel) (2016): 20 - 23. |
| MLA | senturk nilgun METOTREKSAT. Türkderm-Deri Hastalıkları ve Frengi Arşivi, vol.50, no.1(Özel), 2016, ss.20 - 23. |
| AMA | senturk n METOTREKSAT. Türkderm-Deri Hastalıkları ve Frengi Arşivi. 2016; 50(1(Özel)): 20 - 23. |
| Vancouver | senturk n METOTREKSAT. Türkderm-Deri Hastalıkları ve Frengi Arşivi. 2016; 50(1(Özel)): 20 - 23. |
| IEEE | senturk n "METOTREKSAT." Türkderm-Deri Hastalıkları ve Frengi Arşivi, 50, ss.20 - 23, 2016. |
| ISNAD | senturk, nilgun. "METOTREKSAT". Türkderm-Deri Hastalıkları ve Frengi Arşivi 50/1(Özel) (2016), 20-23. |
